FDA Approved: VASOPRESSIN — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal's supplemental application for Vasopressin under ANDA212944, authorizing changes to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Insipidus
• Septic Shock
• Vasodilatory Shock

Drugs mentioned

• VASOPRESSIN (VASOPRESSIN)

Snippet

SUPPL AP for VASOPRESSIN (VASOPRESSIN)